Tag: VHIR

MAGBBRIS project kicks off

The MAGBBRIS Consortium, where Yajie Zhang and Anna Roig participate, celebrated its kickoff meeting during the 26th and 27th of March 2018. The project coordinator, Anna Rosell, welcomed the participants at the Vall d’Hebron Research institute (VHIR), in Barcelona. 

 

During the meetings the participants had the opportunity to understand better the EuroNanoMed Joint Call thanks to Janna Slabbekoorn from the Competitive Calls Unit from VHIR. Afterwards they heard a little bit about each partner’s background related to the project. the members of the consortium could also learn about the past work using endothelial progenitor cells for the treatment of stroke, nanocapsule synthesis, pre-clinical and clinical magnetic resonance imaging, different in vitro models of the blood-brain barrier, manufacturing of high volumes of proteins under GMP conditions and magnetic targeting of nanomaterials.

 

We wish a lot of success to the MAGBBRIS project! 

Congratulations to Elisa Carenza for the Extraordinay PhD Award!

elisa-carenza_premi-extraordinari-doctoratWe congratulate Elisa Carenza, who has been awarded with the Extraordinary PhD Award (Premi Extraordinari de Doctorat) for her thesis entitled Engineering iron oxide nanoparticles for angiogenic therapies“. 

Elisa carried out her PhD here at ICMAB, within the N&N Group, and in collaboration with Vall d’Hebron Research Institute (VHIR), under the supervision of Anna Roig (ICMAB) and Anna Rosell (VHIR), in the framework of the UAB PhD program

The awards ceremony will take place on November 18, 2016, at 6.30 pm, at  Hotel Campus (Edifici Blanc).

Elisa is now working in a startup biopharmaceutical company (Addex Therapeutics) in Geneva (Switzerland), which develops new molecules for the treatment of neurological diseases such as Parkinson’s and epilepsy. Elisa is investigating the effects of these molecules in humans, in different Clinical Research studies. 

Congratulations Elisa!

More information about the Extraordinary PhD award resolution here
The thesis can be found in the UAB Digital Document Repository : http://ddd.uab.cat/record/128025

 

Cooperation project with the Institut de Recerca de la Vall d’Hebron (VHIR): Innovation Prize Finalist!

innovative prize

MAGNET, the cooperation project with the Institut de Recerca de la Vall d’Hebron (VHIR) has been selected as one of the five finalists of the prestigious Innovation Prize. Dr. Anna Rosell, that leads this project at the Neurovacular Research Group, will defend it in Paris on the 12th of September. We wish her best luck!

If you want to read more: “El VHIR patenta una teràpia per potenciar la neuroreparació després de l’ictus”

Magnet – Vall d’Hebron Research Institute – Anna Rosell 
Stroke is a leading cause of death and disability worldwide and neurorepair strategies with advanced cell therapies may become a reality soon. However, this can only be accomplished by achieving the control over the delivery and engraftment of functional cells. The concept of the Magnet therapy is that by labelling endothelial progenitor cells (EPCs) and nanocapsules containing EPCs-growth factors with biocompatible magnetic iron oxide nanoparticles, we will be able to guide their delivery to precise brain areas by externally applying a magnetic field force to enhance neurorepair and recovery.

The techonology is patented and we are currently in search of a company interested in lincense it. Publication of the firsts results can be found in the paper “In vitro angiogenic performance and in vivo brain targeting of magnetized endothelial progenitor cells for neurorepair therapies”

Figure: Image of an endothelial progenitor cell (EPC) taken with a Transmission Soft cryo-X-ray Microscopy from the ALBA Synchroton.